Bibliography

Arti K. Rai

Forthcoming

Building a Better Patent System: Facially Neutral Standards With Disparate Impact, 45 Houston Law Review (forthcoming 2008)
University Software Ownership and Litigation: A First Examination, North Carolina Law Review (forthcoming 2008) (with John R. Allison, Bhaven Sampat, & Colin Crossman)

Works in Progress

Books

Law and the Mental Health System (West Group Publishing, 4th ed. 2004) (with Ralph Reisner and Chris Slobogin).

Articles

Pathways Across the Valley of Death: Novel Intellectual Property Strategies for Accelerated Drug Discovery, VIII Yale Journal of Health Law, Policy & Ethics 53-89 (2008) (with Jerome H. Reichman, Paul F. Uhlir, & Colin Crossman)
Synthetic Biology: Caught Between Property Rights, the Public Domain, and the Commons, 5 PLoS Biology e58 (March 2007) (with James Boyle)
Synthetic Biology: The Intellectual Property Puzzle, 85 Texas Law Review 1745-1768 (2007) (with Sapna Kumar)
The Ends of Intellectual Property: Health as a Case Study, 70 Law & Contemporary Problems 125-130 (Spring 2007)
Who's Afraid of the APA? What the Patent System Can Learn from Administrative Law, 95 Georgetown Law Journal 269-336 (2007) (with Stuart M. Benjamin)
Harnessing and Sharing the Benefits of State Sponsored Research, 21 Berkeley Technology Law Journal 1187-1213 (2006) (with Rebecca S. Eisenberg)
Open and Collaborative Research: A New Model for Biomedicine, in Intellectual Property Rights in Frontier Industries 131-158 (Robert W. Hahn ed., AEI-Brookings Press 2005).
Proprietary Rights and Collective Action: The Case of Biotechnology Research With Low Commercial Value, in International Public Goods and Technology Transfer in a Globalized Intellectual Property Regime 288-306 (Keith E. Maskus & Jerome H. Reichman eds., 2005)
Allocating Power over Fact-Finding in the Patent System, in Symposium Issue on Ideas Into Action: Implementing Reform of the Patent System 19 Berkeley Technology Law Journal 907-922 (2004).
Finding Cures for Tropical Diseases: Is Open Source an Answer?, 1 PLoS Medicine 180-183 (Dec 2004).
The Increasingly Proprietary Nature of Publicly Funded Biomedical Research: Benefits and Threats, in Buying in or Selling Out?: The Commercialization of the American University 117-126 (Donald G. Stein ed., 2004).
Patenting Organisms and Basic Research, and Private Ownership of Inventions, entries in 4 Encyclopedia of Bioethics 1980-1983, 2130-2132 (3rd ed., 2004).
Proprietary Considerations, in 2 Handbook of Stem Cells: Embryonic Stem Cells 793-798 (Robert p. Lanza, ed., Elsevier Academic 2004)
Bayh-Dole Reform and the Progress of Biomedicine, 66 Law & Contemporary Problems 289-315 (Winter/Spring 2003) (with Rebecca Eisenberg).
Engaging Facts and Policy: A Multi-Institutional Approach to Patent System Reform, 103 Columbia Law Review 1035-1135 (2003).
Genome Patents: A Case Study in Patenting Research Tools, 77 Academic Medicine 1368-72 (December 2002).
Genetic Interventions: (Yet) Another Challenge to Allocating Health Care, 39 San Diego Law Review 657-67 (2002).
Health Care Fraud and Abuse: A Tale of Behavior Induced by Payment Structure, 30 Journal of Legal Studies 579-87 (2002).
Locating Gene Patents Within the Patent System, 2 American Journal of Bioethics 18 (Summer 2002).
Pharmacogenetic Interventions, Orphan Groups, and Distributive Justice: The Role of Cost-Benefit Analysis, 19(2) Social Philosophy & Policy 246 (2002).
Specialized Trial Courts: Concentrating Expertise on Fact, 17 Berkeley Technology Law Journal 887-98 (2002).
Evolving Scientific Norms and Intellectual Property Rights: A Reply to Professor Kieff, 95 Northwestern University Law Review 707-13 (2001).
Fostering Cumulative Innovation in the Biopharmaceutical Industry: The Role of Patents and Antitrust, 16 Berkeley Technology Law Journal 813 (2001).
The Information Revolution Reaches Pharmaceuticals: Balancing Innovation Incentives, Cost, and Access in the Post-Genomics Era, 2001 University of Illinois Law Review 173-210.
Addressing the Patent Gold Rush: The Role of Deference to PTO Patent Denials, 2 Washington University Journal of Law & Policy 199-227 (2000).
Intellectual Property Rights in Biotechnology: Addressing New Technology, 34 Wake Forest Law Review 827-47 (1999).
The Physician as a Health Care Proxy, 29 Hastings Center Report 14 (September/October 1999) (with Drs. Mark Siegler and John Lantos).
Regulating Scientific Research: Intellectual Property Rights and the Norms of Science, 94 Northwestern University Law Review 77-152 (1999).
Reflective Choice in Health Care: Using Information Technology to Present Allocation Options, 25 American Journal of Law & Medicine 387(Summer/Fall 1999).
Rationing Through Choice: A New Approach to Cost-Effectiveness Analysis in Health Care, 72 Indiana Law Journal 1015-97 (1997).
Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature, 116(3) Annals of Internal Medicine 338 (1992) (co-authored).